Advertisement

Advertisement

JP:4891 Stock Latest News

TMS Posts Quarterly Loss, Maintains Strong Equity Base and Suspends Guidance

Company AnnouncementsTMS Posts Quarterly Loss, Maintains Strong Equity Base and Suspends Guidance

TMS Enrolls First Japanese Patient in Global Phase II/III Stroke Trial of TMS-007

PremiumCompany Announcements

TMS Enrolls First Japanese Patient in Global Phase II/III Stroke Trial of TMS-007

3M ago

TMS Co., Ltd. Posts Continued Losses but Maintains Strong Equity Base in Shortened Fiscal Year

PremiumCompany Announcements

TMS Co., Ltd. Posts Continued Losses but Maintains Strong Equity Base in Shortened Fiscal Year

3M ago

TMS Posts Loss for Transitional Fiscal Year, Withheld 2026 Guidance Amid Ongoing Uncertainty

PremiumCompany Announcements

TMS Posts Loss for Transitional Fiscal Year, Withheld 2026 Guidance Amid Ongoing Uncertainty

3M ago

TMS Co., Ltd. Reports Financial Losses for Six Months Ending August 2025

PremiumCompany Announcements

TMS Co., Ltd. Reports Financial Losses for Six Months Ending August 2025

7M ago

TMS Co., Ltd. Reports Q1 Losses Amidst Improved Financial Position

PremiumCompany AnnouncementsTMS Co., Ltd. Reports Q1 Losses Amidst Improved Financial Position

10M ago

TMS Co., Ltd. Advances Global Clinical Trial for Stroke Treatment

Company Announcements

TMS Co., Ltd. Advances Global Clinical Trial for Stroke Treatment

1y ago

TMS Co., Ltd. Advances Stroke Treatment Study with PMDA Submission

Company Announcements

TMS Co., Ltd. Advances Stroke Treatment Study with PMDA Submission

1y ago

TMS Co., Ltd. Reports Reduced Losses in Fiscal Year 2025

PremiumCompany Announcements

TMS Co., Ltd. Reports Reduced Losses in Fiscal Year 2025

1y ago

TMS Co., Ltd. Reports Positive Phase I Results for TMS-008

PremiumCompany Announcements

TMS Co., Ltd. Reports Positive Phase I Results for TMS-008

1y ago

TMS Co., Ltd. Announces Royalty Payment from CORXEL Dividend

PremiumCompany Announcements

TMS Co., Ltd. Announces Royalty Payment from CORXEL Dividend

1y ago

TMS Co., Ltd. Aligns Fiscal Year with Global Standards

PremiumCompany Announcements

TMS Co., Ltd. Aligns Fiscal Year with Global Standards

1y ago

TMS Co., Ltd. Partners with Tokushima University for Joint Research

PremiumCompany AnnouncementsTMS Co., Ltd. Partners with Tokushima University for Joint Research

1y ago

TMS Co., Ltd. Advances Stroke Treatment with New Global Trial Approval

Company Announcements

TMS Co., Ltd. Advances Stroke Treatment with New Global Trial Approval

1y ago

TMS Co., Ltd. Presents Promising Stroke Treatment at ISC 2025

Company Announcements

TMS Co., Ltd. Presents Promising Stroke Treatment at ISC 2025

1y ago

TMS Co., Ltd. Reports Nine-Month Financial Results with Net Loss

PremiumCompany Announcements

TMS Co., Ltd. Reports Nine-Month Financial Results with Net Loss

1y ago

TMS Co., Ltd. to Lead Executive Roundtable at WuXi Global Forum 2025

PremiumCompany Announcements

TMS Co., Ltd. to Lead Executive Roundtable at WuXi Global Forum 2025

1y ago

TMS Co., Ltd. Highlights 2024 Achievements and 2025 Goals in Shareholder Letter

PremiumCompany Announcements

TMS Co., Ltd. Highlights 2024 Achievements and 2025 Goals in Shareholder Letter

1y ago

TMS Co., Ltd. to Join J.P. Morgan Healthcare Event

PremiumCompany Announcements

TMS Co., Ltd. to Join J.P. Morgan Healthcare Event

1y ago

TMS Co., Ltd. Highlights Promising Stroke Treatment

PremiumCompany AnnouncementsTMS Co., Ltd. Highlights Promising Stroke Treatment

2y ago

TMS Co., Ltd. Gains U.S. Patent for Kidney Treatment

Company Announcements

TMS Co., Ltd. Gains U.S. Patent for Kidney Treatment

2y ago

TMS Co. Publishes Promising Stroke Treatment Results

Company Announcements

TMS Co. Publishes Promising Stroke Treatment Results

2y ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >